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Abstract
Assessment of the relative impact of diseases and pathogens is important for agencies and other organizations charged
with providing disease surveillance, management and control. It also helps funders of disease-related research to identify
the most important areas for investment. Decisions as to which pathogens or diseases to target are often made using
complex risk assessment approaches; however, these usually involve evaluating a large number of hazards as it is rarely
feasible to conduct an in-depth appraisal of each. Here we propose the use of the H-index (or Hirsch index) as an alternative
rapid, repeatable and objective means of assessing pathogen impact. H-index scores for 1,414 human pathogens were
obtained from the Institute for Scientific Information’s Web of Science (WOS) in July/August 2010. Scores were compared for
zoonotic/non-zoonotic, and emerging/non-emerging pathogens, and across taxonomic groups. H-indices for a subset of
pathogens were compared with Disability Adjusted Life Year (DALY) estimates for the diseases they cause. H-indices ranged
from 0 to 456, with a median of 11. Emerging pathogens had higher H-indices than non-emerging pathogens. Zoonotic
pathogens tended to have higher H-indices than human-only pathogens, although the opposite was observed for viruses.
There was a significant correlation between the DALY of a disease and the H-index of the pathogen(s) that cause it.
Therefore, scientific interest, as measured by the H-index, appears to be a reflection of the true impact of pathogens. The H-
index method can be utilized to set up an objective, repeatable and readily automated system for assessing pathogen or
disease impact.
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Introduction
Assessment of the potential impact of diseases and pathogens is
important for international, national and regional agencies and
other organisations charged with providing disease surveillance
and mitigation measures including implementation of disease
management and control. It is also useful for funders of research so
that they can identify the most important areas for investment.
Decisions as to which specific pathogens or diseases to target are
often made using risk assessment techniques as prioritisation tools.
However, this usually involves evaluating a large number of
hazards where it is not feasible to conduct an in-depth appraisal of
all pathogens or diseases. Qualitative and semi-quantitative risk
assessment approaches are specifically criticised either due to their
potential subjectivity or the large amount of time and physical
resources they use, creating results which may no longer be
accurate by the time they are published. However, most
quantitative methods require some input of expert opinion giving
them a degree of subjectivity as well. In addition, it can be difficult
to identify both parameters and estimates of parameter effects
within the scientific literature, which can then be used within a
quantitative model. All risk assessments are therefore biased in
some way; either by the quality of the evidence utilised, time taken
for its collection and therefore the timeliness of results or by the
opinion of experts employed to make judgements on topics.
Here we propose the use of the H-index (or Hirsch index) to
assess pathogen impact. This index is a bibliometric indicator
obtained using certain bibliographic software packages such as the
Institute for Scientific Information’s Web of Science (WOS) [1].
For any group of keywords or phrases, it measures the number of
published papers, N, that have been cited N or more times. This
simple measure has been found to be a useful indicator of both the
technical productivity and the apparent scientific impact of an
individual within the scientific community [2], and is used within
the recruitment process for scientists. It combines elements of the
quantity of work undertaken (the number of publications, N) and
the quality of work undertaken (the number of citations, also N).
While the H-index is undeniably crude, it has the advantages that
for any given search term it takes only minutes to obtain and is
user-objective; it lends itself therefore to comparison of a large
number of terms (people, pathogens) rather than in-depth
comparison of a few.
This study aimed to examine the potential use of the H-index as
an objective, time and resource efficient measure for the
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prioritisation of pathogens of humans [3]. Evaluation of the
relative impact of pathogens indicated by H-indices with their true
impact was undertaken by comparing the disability adjusted life
year (DALY) estimates for a subset of diseases with the H-index
score for the pathogens that cause them.
The pathogen database being utilised as the study population
also contained information on the taxonomic division in which
pathogens belonged (bacteria and rickettsia (hereafter defined as
bacteria), fungi, helminths, protozoa, viruses and prions (hereafter
defined as viruses)), and whether pathogens were considered
emerging or zoonotic [3]. Differences between H-index scores
were therefore examined for emerging pathogens compared to
those not considered emerging, and for pathogens considered to be
zoonotic (transferable from animals to humans) compared to
human-only pathogens, both generally or stratified by taxonomic
division.
Methods
List of pathogens of humans
A previously generated database of infectious organisms known
to have pathogenic effects upon humans was utilised as the sample
for investigation [3]. Due to difficulty in distinguishing between
them within pathogen searches, European and Far eastern Tick–
borne encephalitis (TBE) were combined in a search for TBE. In
all, 1414 pathogens were therefore studied, of which 38.0% were
bacteria, 21.7% were fungi, 20.3% were helminths, 4.7% were
protozoa and 15.3% were viruses (table 1). 12.3% of pathogens
were identified as emerging, and 61.2% were zoonotic. Emerging
pathogens, as classified by [3], were defined as those that have
appeared in a human population for the first time, or have
occurred previously but are increasing in incidence or expanding
into areas where they had not previously been reported, usually
over the last 20 years. Zoonotic pathogens were defined as those
naturally transmitted between vertebrate animals and man.
Pathogens previously but no longer transmitted from animals,
such as HIV, were not regarded as zoonotic.
Literature searches
Identification of the H-index score of pathogens. H-
index scores were obtained for all pathogen names as given by [3]
using phrase searches enclosed using ‘‘’’ within WOS [1], although
several spelling alterations were needed. All searches were for 1900
to 2009, inclusive, and they were undertaken between July and
August 2010. Searches for viruses were more complex, however,
because of the existence of synonyms and acronyms. Synonyms
and acronyms were obtained from the NCBI taxonomy website
(http://www.ncbi.nlm.nih.gov/Taxonomy/taxonomyhome.html )
or http://www.ictvdb.org/Ictv/index.htm and included as
additional search terms. However, it was observed that some
acronyms were used for more than one virus, or occurred in a
non-viral context. All searches for viruses therefore also included
the term ‘virus’ and excluded any other entities (viral or non-viral)
which shared the acronym. The details for pathogens with the top
20 H-index scores are presented in table 2.
Comparison of H-index scores and DALY estimations
DALYs [4] were developed by the World Health Organization,
and are suggested to be the best measure of the true burden of
disease. They combine morbidity and mortality within a single
metric by including equivalent years of ‘healthy’ life lost by virtue
of being in states of poor health or disability, with an estimation of
the potential years of life lost due to premature death. Japanese life
Table 1. Number and percentage (n/%) of pathogens within taxonomic divisions and whether they are emerging or non-
emerging and zoonotic or affect humans-only according to [3].
n/% Total n =1414 Emerging Not emerging Zoonotic Human-only
Group 174/12.3 1240/87.7 866/61.2 548/38.8
Bacteria or rickettsia 538/38.0 53/9.9 485/90.1 269/50.0 269/50.0
Fungi 307/21.7 16/5.2 291/94.8 116/37.8 191/62.2
Helminths 287/20.3 10/3.5 277/96.5 274/95.5 13/4.5
Protozoa 66/4.7 19/28.8 47/71.2 43/65.2 23/34.8
Viruses or prions 216/15.3 76/35.2 140/64.8 164/75.9 52/24.1
doi:10.1371/journal.pone.0019558.t001
Table 2. Infectious organisms pathogenic to humans with
the top 20 H-index scores following searches of the literature
using WOS [1].
Pathogen Name Group H-index score
Saccharomyces cerevisiae Fungi 456
Human Immunodeficiency Virus 1 Viruses 349
Hepatitis A virus Viruses 317
Hepatitis C virus Viruses 276
Staphylococcus aureus Bacteria 253
Hepatitis B virus Viruses 236
Helicobacter pylori Bacteria 227
Human papillomavirus Viruses 227
Pseudomonas aeruginosa Bacteria 225
Salmonella Typhimurium Bacteria 225
Mycobacterium tuberculosis Bacteria 224
Bacillus subtilis Bacteria 206
Escherichia coli Bacteria 206
Plasmodium falciparum Protozoa 199
Listeria monocytogenes Bacteria 198
Streptococcus pneumoniae Bacteria 186
Candida albicans Fungi 171
Vesicular stomatitis virus Viruses 169
Leishmania major Protozoa 152
Human Herpesvirus 4 Viruses 147
doi:10.1371/journal.pone.0019558.t002
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expectancy statistics are used as the standard for measuring
premature death, and one DALY is equivalent to one year of
healthy life lost. The estimations used within the study were taken
from the most recent Global Burden of Disease report [5]. As
DALY estimations are only calculated for well known and high
impact clinical diseases, comparison was restricted to a short-list of
the pathogens for which H-index scores were calculated (n= 27).
As DALY estimations are of clinical diseases rather than for the
effects of specific pathogens, clinical ailments caused by pathogens
were established, with several pathogens in some cases causing a
single clinical disease. Hence, further bibliographic searches using
WOS were undertaken to re-obtain H-index scores for a
combination of pathogen names, synonyms, acronyms and disease
name. Such searches identified a specific problem for AIDS/HIV,
with the number of papers identified above the maximum WOS
search threshold of 100 000; search terms were removed until the
total number was just under this threshold and an estimate of the
H-index score could therefore be calculated. To clarify that H-
index scores are comparable across different bibliographic indexes
which search various literature sources over differing temporal
periods, H-index scores for a sub-sample of pathogen names were
also derived from searches using SCOPUS [6] and Google Scholar
[7] software.
Statistical analyses
For analyses, parametric methods were used where possible, or
non-parametric approaches were employed if necessary. The
variance structures of H-index scores for grouped emerging versus
non-emerging, and zoonotic versus non-zoonotic pathogens and
for those stratified by taxonomic division were examined using
Levene’s tests. If the two pairs of data had different variances, then
they were either log10+1 transformed or if this did not normalise
the data then non-parametric statistical methods were thereafter
adopted. Differences between H-index scores for emerging versus
non-emerging pathogens, and zoonotic versus non-zoonotic
pathogens, were examined using either a 2-sample T-test or
Mann-Whitney U test (P,0.05).
To examine whether the H-index scores of taxonomic divisions
differed from each other, a Kruskal-Wallis test was used, after an
Anderson–Darling normality test had first been employed to
examine the distribution of the data. Multiple comparison testing
to identify differences between the H-index scores of taxonomic
divisions was also undertaken [8,9].
Examination of the suitability of using the H-index score of
pathogens as an indicator of their impact upon humans was
undertaken by comparison with DALY value estimations previ-
ously published by the World Health Organisation [5]. In this
case, the DALY estimates for a number of diseases were compared
with the combined H-index for the most important pathogens that
cause the diseases as well as the disease name. Anderson–Darling
normality tests were initially used to examine whether the DALY
and H-index score data were normally distributed; the data were
log-transformed prior to analysis by Pearson product-moment
correlation (P.0.05). Comparison of H-index scores derived from
other literature sources was undertaken using Spearman Rank
correlation (P.0.05) as the data were non-normally distributed
even after transformation.
Results
The H-index scores for pathogens from the database of
infectious organisms [3] were highly over-dispersed (minimum
value = 0, maximum value = 456, mean value = 25, median
value = 11, standard deviation = 38; figure 1, table 2) with most
pathogens producing relatively low scores. Those pathogens with
the highest scores were examples of the following: person-to-
person transmitted viruses (Hepatitis A, B or C virus, Human
Herpesvirus 4, Human Immunodeficiency Virus 1, Human
papillomavirus) or bacteria (Helicobacter pylori, Mycobacterium tuber-
culosis), agents causing opportunistic oral and genital infection
(Candida albicans), bacteria causing multiple clinical symptoms
(Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella Typhimur-
ium, Streptococcus pneumonia), food-borne bacterial pathogens
(Escherichia coli, Listeria monocytogenes), model organisms for labora-
tory studies (Bacillus subtilis, Vesicular stomatitis virus), major
tropical illnesses (Plasmodium falciparum, Leishmania major) or yeast
(Saccharomyces cerevisiae); an occasional opportunistic infection but
mainly used within the brewing and baking industries.
Figure 1. Frequency histogram of the H-index scores obtained using phrase searches within Web of Science [1] for the names of
pathogens of humans according to [3].
doi:10.1371/journal.pone.0019558.g001
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Emerging pathogens had significantly higher H-index scores
than non-emerging pathogens (figure 2a; median values: 55.0
versus 10.0, respectively, Mann-Whitney U test, P,0.001). For
zoonotic versus human-only pathogens, there was no significant
difference in their mean scores (figure 2b; mean values: 25.5 versus
23.8, respectively, 2-sample T-test, P=0.425). Once the scores
had been stratified by taxonomic division, emerging bacteria,
fungi, helminths, protozoa and viruses all had significantly higher
H-index scores than non-emerging (P,0.001, table 3, figure 2a).
In addition, zoonotic pathogens within the bacteria and fungi
divisions had significantly higher H-index scores (P,0.001, table 4,
figure 2b) than human-only, but human-only viruses and prions
had significantly higher scores than zoonotic viruses (P,0.001,
table 4, figure 2b).
Figure 2. H-index scores by taxonomic division for (a) emerging and non-emerging or (b) zoonotic and human-only pathogens of
humans, both according to [3].
doi:10.1371/journal.pone.0019558.g002
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There were significant differences between the H-index scores
of some taxonomic groups (Kruskal-Wallis test, P,0.001), with
those of bacteria significantly higher than those of the fungi
(P,0.001), and helminth groups (P,0.001), and the scores of the
protozoa group higher than those of fungi (P=0.002).
Both the H-index score and DALY estimation data were non-
normally distributed (P=0.029 and P,0.010). After log10+1
transformation they were significantly positively correlated
(figure 3, Pearson correlation coefficient = 0.546, P=0.003).
H-index scores calculated using different bibliographic indexes
were significantly positively correlated (WOS and SCOPUS H-
index comparison, P,0.001; WOS and Google Scholar H-index
comparison, P,0.001).
Discussion
This study aimed to examine the use of the H-index as a tool
for assessing the relative impact of pathogens. There are a
number of weaknesses to this approach: the results are
susceptible to a lag in time-to-publication, with newly emerging
pathogens likely to be under-represented and thus have low H-
index scores; the method needs some manual oversight, as false
positives can occur for instance when pathogens are used as
model organisms; biases in results may happen because of
trends in interest in specific pathogens, diseases or research
fields (as a result of regional publication biases or the Matthew
effect; ‘the rich get richer and the poor get poorer’); in addition,
results will need updating to allow for the inclusion of new
research material. The literature searching method also doesn’t
account for the quality of publications in which pathogen
names appear, or the typical number of citations within
different fields. In addition, all bibliographic software packages
incorporate newly published literature into their databases at
different rates and the literature sources included are not
identical in each [10]. Most importantly, the H-index method
does not really measure ‘impact’; it measures scientific interest
in a pathogen or disease.
However, there are also many advantages to the use of the H-
index method. It can be rapidly obtained (one person obtained the
1414 H-indices in two weeks) and has the potential to be
automated and repeated regularly. It is user-objective, and
provides an easily understood quantitative measure. The scores
reflect the wider scientific interest that would be expected to follow
from a pathogen being either zoonotic or emerging. Most
importantly, for a small subset of diseases for which their true
impact has been estimated in terms of DALYS, there is a
significant correlation with H-index scores. Scientific interest, as
measured by the H-index appears to be, therefore, a reasonable
reflection of the true impact of pathogens. In view of this
relationship, outlying points below or above the line are diseases
which have, respectively, relatively low or high scientific interest
considering their true impact (as defined by their DALY
estimation). Intriguingly, the strongest negative outliers are
lymphatic filariasis, ascariasis, hookworm and trichuriasis; all four
of which are nematode infections prevalent in developing
countries. In other words, the H-index may provide a visual
representation of the neglect of certain tropical diseases within the
literature, either because of a lack of funding for research or from
lack of publication of research findings. By contrast, the strongest
positive outliers are poliomyelitis, hepatitis B and C and AIDS;
three out of four of which are significant health problems in the
developed world.
To conclude, this work suggests that scientific interest, indicated
by H-index scores, is a reasonable reflection of the true impact of
Table 3. The results of tests of equal variances, 2-sample T-tests or Mann-Whitney U tests on (log10+1 transformed) H-index scores
for emerging and non-emerging pathogens by taxonomic division.
Taxonomic division
H-index score test of
equal variances
H-index score (Log10+1)
test of equal variances T-test Mann-Whitney U test
Bacteria - P,0.001 - P,0.001
Fungi - P = 0.024 - P,0.001
Helminth - P = 0.021 - P,0.001
Protozoa - P = 0.143 P,0.001 -
Virus - P = 0.087 P,0.001 -
doi:10.1371/journal.pone.0019558.t003
Table 4. The results of tests of equal variances, 2-sample T-tests or Mann-Whitney U tests on (log10+1 transformed) H-index scores
for zoonotic and human-only pathogens by taxonomic division.
Taxonomic division
H-index score test of
equal variances
H-index score (Log10+1)
test of equal variances T-test Mann-Whitney U test
Bacteria P,0.001 P = 0.706 P,0.001 -
Fungi P = 0.185 P = 0.106 P,0.001 -
Helminth P = 0.572 - P = 0.851 -
Protozoa P = 0.597 - P = 0.322 -
Virus P,0.001 P,0.001 - P,0.001
doi:10.1371/journal.pone.0019558.t004
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pathogens. Further research may show that a rapid increase in an
H-index score can perhaps be used as an indicator of disease or
pathogen emergence. A full list of H-index scores can be obtained
from the authors.
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